Barbara Ann Krulewicz

Title: The Innovations of Barbara Ann Krulewicz

Introduction

Barbara Ann Krulewicz is a notable inventor based in Bloomfield, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the production of plasmid DNA. With a total of 3 patents to her name, her work has implications for pharmaceutical applications, including gene therapy and vaccination.

Latest Patents

One of her latest patents relates to a method for increasing the yield of plasmid DNA production. This method involves selecting a highly productive clonal subtype of a strain, such as the DH5 strain, which harbors a DNA plasmid. The cultivation of this clonal subtype is conducted using fed-batch fermentation in a chemically-defined medium. The described plasmid DNA production process can generate record quantities of plasmid DNA when cultivated on an industrial scale. This innovative method is particularly useful for producing pharmaceutical-grade DNA for polynucleotide vaccination and gene therapy treatment regimens.

Career Highlights

Throughout her career, Barbara has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Merck & Company, Inc. Her experience in these organizations has contributed to her expertise in biotechnology and innovation.

Collaborations

Barbara has collaborated with notable professionals in her field, including Michel M Chartrain and Laura Kizer Bentley. These collaborations have likely enriched her work and expanded her impact in the industry.

Conclusion

Barbara Ann Krulewicz's contributions to the field of biotechnology through her patents and collaborations highlight her role as an influential inventor. Her innovative methods for plasmid DNA production are paving the way for advancements in gene therapy and vaccination.